President/CEO of Conceptus Inc. (CPTS, Financial) Mark M Sieczkarek sells 1,689 shares of CPTS on 10/22/2009 at an average price of $20 a share.
Conceptus Inc. designs and develops minimally invasive devices for reproductive medical applications. Conceptus' focus is to develop its STOP non-surgical permanent contraception device for women. STOP is designed to be a less-invasive safer and less costly alternative to surgical sterilization more commonly known as tubal ligation. The STOP device is designed to achieve contraception by elliciting a tissue response which occludes the fallopian tubes. Conceptus Inc. has a market cap of $556.1 million; its shares were traded at around $18.19 with a P/E ratio of 72.8 and P/S ratio of 5.5.
CPTS is in the portfolios of PRIMECAP Management.
Conceptus Inc. designs and develops minimally invasive devices for reproductive medical applications. Conceptus' focus is to develop its STOP non-surgical permanent contraception device for women. STOP is designed to be a less-invasive safer and less costly alternative to surgical sterilization more commonly known as tubal ligation. The STOP device is designed to achieve contraception by elliciting a tissue response which occludes the fallopian tubes. Conceptus Inc. has a market cap of $556.1 million; its shares were traded at around $18.19 with a P/E ratio of 72.8 and P/S ratio of 5.5.
CPTS is in the portfolios of PRIMECAP Management.
Insiders' Positions with CPTS
- Sell:: President/CEO on 09/23/2009 Mark M Sieczkarek sold 95,387 shares of CPTS stock at the average price of 19, the price of the stock has decreased by 4.26% since
- Sell:: President/CEO on 09/09/2009 Mark M Sieczkarek sold 4,613 shares of CPTS stock at the average price of 19, the price of the stock has decreased by 4.26% since
Insiders' Positions with CPTS
- Sell:: VP of Sales on 10/22/2009 Ulric E Iii Cote sold 6,397 shares of CPTS stock at the average price of 20, the price of the stock has decreased by 9.05% since
- Sell:: VP of Sales on 09/09/2009 Ulric E Iii Cote sold 9,013 shares of CPTS stock at the average price of 19, the price of the stock has decreased by 4.26% since
- Sell:: VP of Sales on 08/25/2009 Ulric E Iii Cote sold 987 shares of CPTS stock at the average price of 19, the price of the stock has decreased by 4.26% since
- Sell:: VP of Sales on 08/07/2009 Ulric E Iii Cote sold 5,000 shares of CPTS stock at the average price of 18, the price of the stock has increased by 1.06% since
- Sell:: Chairman of the Board on 06/12/2009 Kathryn Tunstall sold 30,000 shares of CPTS stock at the average price of 16.31, the price of the stock has increased by 11.53% since
